BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nakajima K, Watanabe O, Mochizuki M, Nakasone A, Ishizuka N, Murashima A. Pregnancy outcomes after exposure to tocilizumab: A retrospective analysis of 61 patients in Japan. Mod Rheumatol 2016;26:667-71. [PMID: 26873562 DOI: 10.3109/14397595.2016.1147405] [Cited by in Crossref: 47] [Cited by in F6Publishing: 39] [Article Influence: 9.4] [Reference Citation Analysis]
Number Citing Articles
1 Beltagy A, Aghamajidi A, Trespidi L, Ossola W, Meroni PL. Biologics During Pregnancy and Breastfeeding Among Women With Rheumatic Diseases: Safety Clinical Evidence on the Road. Front Pharmacol 2021;12:621247. [PMID: 34122062 DOI: 10.3389/fphar.2021.621247] [Reference Citation Analysis]
2 De Lorenzo R, Ramirez GA, Punzo D, Lorioli L, Rovelli R, Canti V, Barera G, Rovere-Querini P. Neonatal outcomes of children born to mothers on biological agents during pregnancy: State of the art and perspectives. Pharmacol Res 2020;152:104583. [PMID: 31816434 DOI: 10.1016/j.phrs.2019.104583] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Henson LJ, Afsar S, Davenport L, Purvis A, Poole EM, Truffinet P. Pregnancy outcomes in patients treated with leflunomide, the parent compound of the multiple sclerosis drug teriflunomide. Reprod Toxicol 2020;95:45-50. [PMID: 32407881 DOI: 10.1016/j.reprotox.2020.04.073] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Karakaş Ö, Erden A, Ünlü S, Erol SA, Goncu Ayhan Ş, Özdemir B, Tanacan A, Ozden Tokalioglu E, Ateş İ, Moraloğlu Tekin Ö, Omma A, Şahin D, Küçükşahin O. Can Anakinra and corticosteroid treatment be an effective option in pregnant women with severe Covid-19? Women Health 2021;61:872-9. [PMID: 34551674 DOI: 10.1080/03630242.2021.1981517] [Reference Citation Analysis]
5 Góralczyk A, Kolossa K, Waszczak-Jeka M, Adamczak R, Jeka S. The exposure to biologic and targeted synthetic disease-modifying antirheumatic drugs in pregnancy and lactation. Postepy Dermatol Alergol 2020;37:306-12. [PMID: 32774212 DOI: 10.5114/ada.2020.96294] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
6 Ogata A, Kato Y, Higa S, Yoshizaki K. IL-6 inhibitor for the treatment of rheumatoid arthritis: A comprehensive review. Mod Rheumatol 2019;29:258-67. [PMID: 30427250 DOI: 10.1080/14397595.2018.1546357] [Cited by in Crossref: 53] [Cited by in F6Publishing: 51] [Article Influence: 26.5] [Reference Citation Analysis]
7 Oliva M, Hsu K, Alsamarai S, Chavez V, Ferrara L. Clinical improvement of severe COVID-19 pneumonia in a pregnant patient after caesarean delivery. BMJ Case Rep 2020;13:e236290. [PMID: 32675129 DOI: 10.1136/bcr-2020-236290] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
8 Borisow N, Hellwig K, Paul F. [Neuromyelitis optica spectrum disorder and pregnancy]. Nervenarzt 2018;89:666-73. [PMID: 29383411 DOI: 10.1007/s00115-018-0486-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 Holmøy T, Høglund RA, Illes Z, Myhr KM, Torkildsen Ø. Recent progress in maintenance treatment of neuromyelitis optica spectrum disorder. J Neurol 2020. [PMID: 33011853 DOI: 10.1007/s00415-020-10235-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
10 Carnovale C, Parisi F, Battini V, Zavatta A, Cheli S, Cattaneo D, Gringeri M, Mosini G, Guarnieri G, Cammarata G, Cetin I. The use of biological agents in pregnant women affected by autoimmune disorders: Why we need more research of this neglected area. Pharmacol Res 2021;171:105786. [PMID: 34314858 DOI: 10.1016/j.phrs.2021.105786] [Reference Citation Analysis]
11 Murashima A, Yakuwa N, Koinuma S, Uno C, Takai C, Fujioka I, Goto M, Ito N, Watanabe O, Yamatani A. The advances in dealing with the safety of medicated drugs in pregnancy. Glob Health Med 2021;3:175-9. [PMID: 34250294 DOI: 10.35772/ghm.2020.01120] [Reference Citation Analysis]
12 Jiménez-Lozano I, Caro-Teller JM, Fernández-Hidalgo N, Miarons M, Frick MA, Batllori Badia E, Serrano B, Parramon-Teixidó CJ, Camba-Longueira F, Moral-Pumarega MT, San Juan-Garrido R, Cabañas Poy MJ, Suy A, Gorgas Torner MQ. Safety of tocilizumab in COVID-19 pregnant women and their newborn: A retrospective study. J Clin Pharm Ther 2021;46:1062-70. [PMID: 33638257 DOI: 10.1111/jcpt.13394] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
13 Wiese MD, Berry MJ, Hissaria P, Darby JRT, Morrison JL. COVID-19: can we treat the mother without harming her baby? J Dev Orig Health Dis 2021;:1-11. [PMID: 33487213 DOI: 10.1017/S2040174420001403] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Dalkilic E, Coskun BN, Yağız B, Pehlivan Y. A successful pregnancy in a patient with Takayasu's arteritis under tocilizumab treatment: A longitudinal case study. Int J Rheum Dis 2019;22:1941-4. [DOI: 10.1111/1756-185x.13687] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
15 Bongenaar M, Smeele HTW, Lubberts E, Dolhain RJEM. IL-6 but Not TNFα Levels Are Associated With Time to Pregnancy in Female Rheumatoid Arthritis Patients With a Wish to Conceive. Front Pharmacol 2020;11:604866. [PMID: 33362560 DOI: 10.3389/fphar.2020.604866] [Reference Citation Analysis]
16 Saito J, Yakuwa N, Kaneko K, Takai C, Goto M, Nakajima K, Yamatani A, Murashima A. Tocilizumab during pregnancy and lactation: drug levels in maternal serum, cord blood, breast milk and infant serum. Rheumatology 2019;58:1505-7. [DOI: 10.1093/rheumatology/kez100] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
17 Scavone C, Sportiello L, Sullo MG, Ferrajolo C, Ruggiero R, Sessa M, Berrino PM, di Mauro G, Berrino L, Rossi F, Rafaniello C, Capuano A; BIO-Cam Group. Safety Profile of Anticancer and Immune-Modulating Biotech Drugs Used in a Real World Setting in Campania Region (Italy): BIO-Cam Observational Study. Front Pharmacol 2017;8:607. [PMID: 28932193 DOI: 10.3389/fphar.2017.00607] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
18 Tada Y, Sakai M, Nakao Y, Maruyama A, Ono N, Koarada S. Placental transfer of tocilizumab in a patient with rheumatoid arthritis. Rheumatology (Oxford) 2019;58:1694-5. [PMID: 31329987 DOI: 10.1093/rheumatology/kez155] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
19 Favilli A, Mattei Gentili M, Raspa F, Giardina I, Parazzini F, Vitagliano A, Borisova AV, Gerli S. Effectiveness and safety of available treatments for COVID-19 during pregnancy: a critical review. J Matern Fetal Neonatal Med 2020;:1-14. [PMID: 32508168 DOI: 10.1080/14767058.2020.1774875] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
20 Nguyen H, Ahmed K, Luo W, Flint J, Giles I. A Systematic Review of the safety of non-TNF inhibitor biologic and targeted synthetic drugs in rheumatic disease in pregnancy. Semin Arthritis Rheum 2021;51:1205-17. [PMID: 34689007 DOI: 10.1016/j.semarthrit.2021.09.004] [Reference Citation Analysis]
21 Mao-Draayer Y, Thiel S, Mills EA, Chitnis T, Fabian M, Katz Sand I, Leite MI, Jarius S, Hellwig K. Neuromyelitis optica spectrum disorders and pregnancy: therapeutic considerations. Nat Rev Neurol 2020;16:154-70. [PMID: 32080393 DOI: 10.1038/s41582-020-0313-y] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 21.0] [Reference Citation Analysis]
22 Jorgensen SCJ, Lapinsky SE. Tocilizumab for coronavirus disease 2019 in pregnancy and lactation: a narrative review. Clin Microbiol Infect 2021:S1198-743X(21)00476-6. [PMID: 34438068 DOI: 10.1016/j.cmi.2021.08.016] [Reference Citation Analysis]
23 Manchanda K, Singh J, Bhagat R, Tiwana IK, Singh H. Safety of pharmacological options for the management of COVID-19 in pregnant women: An Indian perspective. Int J Risk Saf Med 2021;32:3-17. [PMID: 33386817 DOI: 10.3233/JRS-200060] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 Bermas BL. Lactation and Management of Postpartum Disease. Rheum Dis Clin North Am 2017;43:249-62. [PMID: 28390567 DOI: 10.1016/j.rdc.2016.12.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
25 Nakamura E, Kotani T, Hiramatsu Y, Hata K, Yoshikawa A, Matsumura Y, Tokai N, Wada Y, Fujita D, Takeuchi T. Simplified disease activity index and clinical disease activity index before and during pregnancy correlate with those at postpartum in patients with rheumatoid arthritis. Mod Rheumatol 2021;31:809-16. [PMID: 32990114 DOI: 10.1080/14397595.2020.1829342] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 LaHue SC, Anderson A, Krysko KM, Rutatangwa A, Dorsey MJ, Hale T, Mahadevan U, Rogers EE, Rosenstein MG, Bove R. Transfer of monoclonal antibodies into breastmilk in neurologic and non-neurologic diseases. Neurol Neuroimmunol Neuroinflamm 2020;7:e769. [PMID: 32461351 DOI: 10.1212/NXI.0000000000000769] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 9.0] [Reference Citation Analysis]
27 Morel J, Tournadre A, Sellam J, Bouhnik Y, Cornec D, Devauchelle-Pensec V, Dieudé P, Goupille P, Kluger N, Lazaro E, Le Goff B, de Lédinghen V, Lequerré T, Nocturne G, Seror R, Truchetet ME, Verhoeven F, Pham T, Richez C. Practical Management of patients on anti-IL6R therapy: Practical guidelines drawn up by the Club Rhumatismes et Inflammation (CRI). Joint Bone Spine 2021;88:105221. [PMID: 34183155 DOI: 10.1016/j.jbspin.2021.105221] [Reference Citation Analysis]
28 Borisow N, Hellwig K, Paul F. Neuromyelitis optica spectrum disorders and pregnancy: relapse-preventive measures and personalized treatment strategies. EPMA J 2018;9:249-56. [PMID: 30174761 DOI: 10.1007/s13167-018-0143-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
29 Giampreti A, Eleftheriou G, Gallo M, Butera R, Contessa G, Faraoni L, Sangiovanni A, Negri G, Falchi G, Bacis G. Medications prescriptions in COVID-19 pregnant and lactating women: the Bergamo Teratology Information Service experience during COVID-19 outbreak in Italy. J Perinat Med 2020;48:1001-7. [PMID: 33055313 DOI: 10.1515/jpm-2020-0339] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Balbi GGM, Domingues V, Balbi GGM, De Jesús GR, Levy RA. Use of synthetic and biologic DMARDs during pregnancy. Expert Rev Clin Immunol 2019;15:27-39. [PMID: 30365902 DOI: 10.1080/1744666X.2019.1541739] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
31 Köhler BM, Günther J, Kaudewitz D, Lorenz HM. Current Therapeutic Options in the Treatment of Rheumatoid Arthritis. J Clin Med 2019;8:E938. [PMID: 31261785 DOI: 10.3390/jcm8070938] [Cited by in Crossref: 48] [Cited by in F6Publishing: 37] [Article Influence: 24.0] [Reference Citation Analysis]
32 Heuser CC, Hulinsky RS, Jackson GM. Caudal Regression Syndrome. Obstetric Imaging: Fetal Diagnosis and Care. Elsevier; 2018. pp. 291-294.e1. [DOI: 10.1016/b978-0-323-44548-1.00059-0] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
33 D'Souza R, Wuebbolt D, Andrejevic K, Ashraf R, Nguyen V, Zaffar N, Rotstein D, Wyne A. Pregnancy and Neuromyelitis Optica Spectrum Disorder - Reciprocal Effects and Practical Recommendations: A Systematic Review. Front Neurol 2020;11:544434. [PMID: 33178102 DOI: 10.3389/fneur.2020.544434] [Reference Citation Analysis]
34 Jara LJ, Cruz-Dominguez MDP, Saavedra MA. Impact of infections in autoimmune rheumatic diseases and pregnancy. Curr Opin Rheumatol 2019;31:546-52. [PMID: 31169546 DOI: 10.1097/BOR.0000000000000636] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Ghalandari N, Dolhain RJEM, Hazes JMW, van Puijenbroek EP, Kapur M, Crijns HJMJ. Intrauterine Exposure to Biologics in Inflammatory Autoimmune Diseases: A Systematic Review. Drugs 2020;80:1699-722. [PMID: 32852745 DOI: 10.1007/s40265-020-01376-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
36 Louchet M, Sibiude J, Peytavin G, Picone O, Tréluyer JM, Mandelbrot L. Placental transfer and safety in pregnancy of medications under investigation to treat coronavirus disease 2019. Am J Obstet Gynecol MFM 2020;2:100159. [PMID: 32838264 DOI: 10.1016/j.ajogmf.2020.100159] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
37 Moriyama M, Wada Y, Minamoto T, Kondo M, Honda M, Murakawa Y. Unexpectedly lower proportion of placental transferred tocilizumab relative to whole immunoglobulin G: a case report. Scand J Rheumatol 2020;49:165-6. [PMID: 31436129 DOI: 10.1080/03009742.2019.1639821] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
38 Naqvi M, Zakowski P, Glucksman L, Smithson S, Burwick RM. Tocilizumab and Remdesivir in a Pregnant Patient With Coronavirus Disease 2019 (COVID-19). Obstet Gynecol 2020;136:1025-9. [PMID: 32618794 DOI: 10.1097/AOG.0000000000004050] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 19.0] [Reference Citation Analysis]
39 Soh MC, Moretto M. The use of biologics for autoimmune rheumatic diseases in fertility and pregnancy. Obstet Med 2020;13:5-13. [PMID: 32284726 DOI: 10.1177/1753495X19841799] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]